Obesity drugs set to dominate next 50 years of medicine: Experts
Experts believe that GLP-1 agonists like semaglutide and tirzepatide will dominate medicine for 50 years due to rising obesity. Dr Lakshmi Lavanya, Endocrinologist affirmed metformin remains indispensable as first-line for diabetes, PCOD, and insulin resistance. Combined use yields major weight loss, reversing comorbidities, but discontinuation causes 50% regain, requiring lifelong therapy.